Skip to content
Life Sciences Series A Founded 2023

Synthesize Bio

Provider of AI-generated gene expression data for biological research purposes. The company offers a platform enabling scientists to generate and analyze genomic data. It allows users to customize AI models, combine AI and experimental data, and visualize expression data. The platform supports molecular experiment design, synthetic control generation, and rare sample augmentation. It also facilitates data analysis,…

📍 Seattle, United States · Genomics,

Funding snapshot

Last roundSeries A
Amount$10M
Date16 September 2025
Total raised$10M
Team size21

About

Provider of AI-generated gene expression data for biological research purposes. The company offers a platform enabling scientists to generate and analyze genomic data. It allows users to customize AI models, combine AI and experimental data, and visualize expression data. The platform supports molecular experiment design, synthetic control generation, and rare sample augmentation. It also facilitates data analysis, collaboration, and access to preprocessed public data. The company operates in the Genomics sector with additional focus on Life Sciences Tech and Life Sciences Tech. Its business model centers on Clinical Data Analysis. Founded in 2023, headquartered in Seattle, United States. The company has raised $10.0M at the Series A stage. Backed by investors including Madrona.

Business model

Life Sciences Tech > Research & Development > Drug Informatics > Clinical Data Analysis,

Genomics > Genomics Services > Bioinformatics,

Life Sciences Platforms and Tools > Research Services > Genomics

Team background

College Wise > University of California (Berkeley)

Institutional investors

Madrona

Latest coverage

No articles yet.

Raising like Synthesize Bio?

Analyze your pitch deck before your next raise.

Analyze My Deck →